The Impact of CRISPR-Cas System on Antiviral Therapy

Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein nuclease (Cas) is identified as an adaptive immune system in archaea and bacteria. Type II of this system, CRISPR-Cas9, is the most versatile form that has enabled facile and efficient targeted genome editing. Vira...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hadi Bayat, Fatemeh Naderi, Amjad Hayat Khan, Arash Memarnejadian, Azam Rahimpour
Natura: Artigo
Lingua:Inglês
Pubblicazione: Tabriz University of Medical Sciences 2018-11-01
Serie:Advanced Pharmaceutical Bulletin
Soggetti:
CRISPR-Cas
Antiviral therapy
Genome editing
Latent viruses
Delivery system
Accesso online:https://apb.tbzmed.ac.ir/PDF/apb-19443
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi